Getz Pharma (Private) Limited, the largest branded generic pharmaceutical company in Pakistan, started its operations in 1995. Since its inception, Getz Pharma has shown unparalleled growth both in qualitative as well as quantitative aspects. According to Information Medical Statistics (IMS), Getz Pharma was ranked 198th out of 200 pharma companies in Pakistan in the year 1995, but in 20 years has achieved the third position among 800 pharmaceutical companies and has been recognized as one of the fastest-growing pharma firms in Pakistan.
Getz Pharma’s products are manufactured at its state of the art, cGMP approved pharmaceutical plant at Karachi and tested at its Quality Control Laboratory which is pre-qualified by the World Health Organization (WHO). The company’s therapeutic segments in Pakistan include the following:
A large number of Getz Pharma brands hold market leadership in their respective classes, including Lipiget (Atorvastatin), Getryl (Glimipride), Ribazole (Ribavarin), Risek (Omeprazole), and Uniferon (Interferon alfa-2b).